U.S. Healthtech Stock News

NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Adeia (ADEA) Signs RPX Licensing Deal, Is The Stock Fully Valued?

Adeia (ADEA) stock is in focus after the company entered a multi-year license agreement with RPX Corporation, giving ten RPX member companies access to Adeia's media intellectual property portfolio. See our latest analysis for Adeia. For context, Adeia’s share price has climbed 12.02% over the past 30 days and 27.84% over the past 90 days, contributing to an 82.31% year to date share price return and a 1 year total shareholder return of 123.73%. Investors may view this performance as being...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Opera (OPRA) Is Up 9.6% After Launching Global Stablecoin MiniPay Card Via Visa Integration

In June 2026, Opera’s MiniPay launched the MiniPay Card in collaboration with Visa and Gnosis Pay, enabling eligible users across Europe, Africa, Latin America and Southeast Asia to spend stablecoin balances via a digital Visa debit card at over 175 million merchant locations worldwide. By linking stablecoin wallets to Visa’s global network and integrating with Apple Pay and Google Pay, MiniPay is turning crypto-style digital dollars into everyday spending power in many high-growth and...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

QXO Stock And Other US Dollar Beneficiaries Investors May Want To Watch

With the Dow Jones and S&P 500 at record highs, chip stocks powering ahead, oil prices easing, and the US dollar at multi decade highs, currency moves are quietly reshaping the risk and opportunity set for stock investors. A stronger dollar can help some companies and squeeze others, depending on where they earn and spend their money. This article focuses on US Dollar Beneficiaries and looks at how the latest macro shifts might affect them. It will walk through 3 stocks from the screener that...
NYSE:PRKS
NYSE:PRKSHospitality

What United Parks & Resorts (PRKS)'s Russell Index Removals Mean For Shareholders

On 27 June 2026, United Parks & Resorts Inc. was removed from several Russell value and small-cap benchmarks, including the Russell 2000 Value, Russell 2500 Value, Russell 3000 Value, Russell Small Cap Comp Value, Russell 3000E Value, and the Russell 2000 Value-Defensive Index. This broad index removal matters because it can trigger portfolio adjustments by index-tracking funds, potentially affecting liquidity, investor mix, and how the market views the company’s profile. Against this...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin Stock And 2 Defense And Energy Names Investors Are Watching

Geopolitical shocks can change market drivers overnight, and the latest missile and drone attacks in Eastern Europe are a reminder that conflict risk is also investment risk. When military and energy infrastructure are hit, capital often shifts toward companies directly exposed to the news, whether through defense technologies, fuel supply, or critical services. This article breaks down 3 stocks from our Defense and Energy Stocks With Geopolitical Upside Exposure screener that appear...
NYSE:NOC
NYSE:NOCAerospace & Defense

What Northrop Grumman (NOC)'s Expanded Navy EW Contract Means For Shareholders

In late June 2026, Northrop Grumman announced a US$312.34 million contract modification to continue producing advanced Surface Electronic Warfare Improvement Program Block Three systems for the U.S. Navy, with work scheduled through August 2029. This award reinforces Northrop Grumman’s role in electronic warfare, a critical capability area that may influence how investors view its long-term defense technology exposure. Next, we will examine how this expanded SEWIP Block Three contract aligns...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Kuehne + Nagel Stock Is a Key Freight Play as Tariff Costs Rise

Tariffs and freight costs are suddenly front and center again, and that matters directly for the stocks you own. When shipping rates spike and new US tariffs loom over imports from China, Europe and other key partners, some companies see extra revenue, while others face squeezed profit margins and tougher decisions on pricing. This article focuses on that tension, using our Tariff and Freight Disruption Stocks With Direct Supply Chain Exposure screener to pick out 3 stocks exposed to the...
NYSE:HII
NYSE:HIIAerospace & Defense

New Navy Contract And Index Moves Could Be A Game Changer For Huntington Ingalls (HII)

In June 2026, Huntington Ingalls Industries (HII) was added to the Russell 1000 Value-Defensive and Russell 1000 Defensive Indexes, secured a US$417.7 million five-year Navy elevator maintenance contract, opened the new Carrier Refueling Overhaul Workcenter at Newport News, and began fabricating the future USS John F. Lehman (DDG 137). Together, these developments underscore HII’s expanding role across both new-build and long-term sustainment work for the U.S. Navy, while also aligning the...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

Sezzle (SEZL) Loses Russell Value Spots, Is The Rally Already Priced In?

Sezzle (SEZL) has been dropped from several Russell value benchmarks, including the Russell 2000 Value, even as Oppenheimer highlights the company’s growth profile, product development, and exposure to discretionary spending trends. See our latest analysis for Sezzle. At a share price of $175.18, Sezzle has seen strong recent momentum, with a 30 day share price return of 42.96% and a 90 day share price return of 174.75%. The 1 year total shareholder return of 1.67% suggests short term...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Does Encore Capital Group’s (ECPG) Russell 2000 Defensive Inclusion Redefine Its Consumer Finance Risk Profile?

On 27 June 2026, Encore Capital Group, Inc. was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, shortly after its CIO presented at the Confidential Computing Summit in San Francisco. These index additions can increase visibility and passive fund interest in Encore, potentially reinforcing its positioning as a more defensively oriented consumer finance name. Next, we’ll examine how Encore’s inclusion in the Russell 2000 defensive indices interacts...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Systems (CSCO) Could Be 6% Overvalued Following AI Revenue Guidance Lift

Cisco Systems (CSCO) is back in focus after an analyst upgrade tied to an improved earnings outlook, stronger guidance for AI infrastructure revenue, and new alliances in enterprise AI and quantum secure networking. See our latest analysis for Cisco Systems. Despite a slight pullback in the last week and month, with the 7 day share price return down 2.27% and the 30 day share price return down 3.56% to US$117.01, Cisco Systems has seen strong momentum over longer periods, including a 90 day...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

IonQ Stock And 2 Quantum Computing Shares Investors Are Watching

Quantum computing stocks sit at the crossroads of high end research and real world problem solving at a time when global data, supply chains and pricing pressures are all in focus for investors. With inflation trends mixed, interest rates still central to markets, and growth signals varying by region, some readers are looking beyond traditional sectors to themes that are driven by long term science and specialised expertise rather than short term demand swings. This Quantum Computing Stocks...
NYSE:IFF
NYSE:IFFChemicals

Does IFF's New Light-Activated Fragrance Platform Deepen Its Innovation Moat Or Test Its Discipline?

International Flavors & Fragrances recently launched SENSORA™, a patent-pending, light-activated pro-fragrance technology designed to deliver evolving, long-lasting scent experiences across home, fabric, and personal care products, with its first application Floral Fusion targeted at liquid detergents. This technology gives perfumers finer control over how fragrances unfold for days after activation, potentially strengthening IFF’s position in higher-value, performance-focused scent...
NYSE:SLVM
NYSE:SLVMForestry

Is Sylvamo (SLVM) Undervalued As Russell Index Removal Reshapes Demand?

Sylvamo (SLVM) was removed from several Russell growth benchmarks on 27 June, a technical index change that can influence how index-linked funds and some active managers size their positions in the stock. See our latest analysis for Sylvamo. That index removal comes after a period of softer momentum for Sylvamo, with the share price down 5.95% over the past week and 21.62% year to date. The 3 year total shareholder return is modestly positive at 2.20%, suggesting recent selling pressure is...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

Does LifeStance Health (LFST) Losing Russell Index Spots Recast Its Role in Investors’ Portfolios?

In late June 2026, LifeStance Health Group, Inc. was removed from several Russell indices, including the Russell 2000 Growth-Defensive and multiple value benchmarks, following the latest reconstitution. This broad index exit is significant because it can alter how passive funds and benchmark-aware investors gain or maintain exposure to the stock. We’ll now explore how LifeStance Health’s removal from key Russell indices shapes the company’s investment narrative and future investor...
NYSE:VZ
NYSE:VZTelecom

Verizon Stock Leads High Yield Picks For A Higher Rate World

With the Federal Reserve now signaling at least one rate increase in 2026, higher borrowing costs and pressure on valuation multiples are back in focus. For income investors, that can put more attention on stocks that already pay higher dividends and carry moderate risk profiles, rather than relying on price gains alone. This article pulls from a High Dividend Yield Stocks screener built around the Fed’s latest stance and related inflation worries, and will walk through 3 stocks that appear...
NYSE:CRL
NYSE:CRLLife Sciences

Charles River Laboratories International (CRL) On Lilly TuneLab Deal And The Valuation Debate

AI partnership with Lilly TuneLab puts Charles River Laboratories International stock in focus Charles River Laboratories International (CRL) has drawn fresh attention after announcing a collaboration with Lilly TuneLab, an AI and machine learning drug discovery platform created by Eli Lilly and Company. The agreement positions Charles River to supply nonclinical testing services to TuneLab participants, standardizing protocols across the platform and supporting AI models that aim to...
NYSE:DRD
NYSE:DRDMetals and Mining

Will Gold’s Sharpest Selloff in 13 Years Recast DRDGOLD's (DRD) Vision 2028 Narrative?

In the recent quarter, gold prices experienced their sharpest selloff in 13 years, drawing attention to DRDGOLD Limited, Newmont Corporation and Barrick Mining Corporation as potential beneficiaries of the volatility. For DRDGOLD, the focus has fallen on its Vision 2028 expansion plan and debt-free balance sheet, which some investors see as strengthening its longer-term appeal despite near-term price pressure on gold. We’ll now explore how DRDGOLD’s Vision 2028 growth plan and solid...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Oracle Stock Leads 3 Founder Backed Tech Picks Riding The AI Cloud Build

Founder led companies can be a useful way to focus on leaders who are deeply tied to the future of their business at a time when global signals are mixed, inflation trends differ by region, and central banks are weighing their next moves. While manufacturing, trade, housing, and consumer confidence all send a mixed but resilient picture, this screener filters for founders who still have skin in the game and a long term mindset. In this article, there is a closer look at 3 stocks from the...
NasdaqGS:VNET
NasdaqGS:VNETIT

VNET Group (VNET) In Focus Following China’s AI Push And An Undervalued View

China’s decision to commit $295b to data center and AI infrastructure has put VNET Group (NasdaqGS:VNET) in focus, with the stock reacting to expectations for higher demand across its hosting and cloud services. See our latest analysis for VNET Group. The recent jump in VNET Group’s share price, including a 1-day share price return of 9.58% and 7-day share price return of 8.10%, comes after China’s $295b AI and data center plan refocused attention on high beta infrastructure stocks. This is...
NYSE:VRT
NYSE:VRTElectrical

Western Digital Stock Leads 3 AI Infrastructure Picks Tied To Data Center Demand

Global markets are sending mixed signals, with manufacturing activity, inflation trends, and bond yields pulling in different directions across regions. In this kind of patchwork, investors often look for themes tied to real, physical demand rather than short term sentiment swings. The AI Infrastructure Stocks screener focuses on companies that supply the data centers, power, and cooling that AI systems rely on, where demand is tied to hardware build out rather than just software hype. In...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Is Personalis (PSNL) Fully Valued Following Its Sharp Share Price Run?

Recent Performance Snapshot for Personalis Stock Personalis (PSNL) has drawn fresh attention after a stretch of strong share price performance, with the stock up over the past week, month, past 3 months and year, alongside positive annual revenue and net income growth figures. At a last close of $13.79, Personalis carries a market value of about $1.4b, supported by reported revenue of $64.515 million and a net loss of $95.552 million, which keeps profitability in focus for investors. See our...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP) Joins Russell Midcap On A Fair Value Gap Comes Into View

Roper Technologies (ROP) has just shifted index tiers, moving out of the Russell Top 200 indices and into the Russell Midcap and Russell Midcap Value benchmarks, a change that can influence trading flows and liquidity. See our latest analysis for Roper Technologies. That index reshuffle comes as Roper Technologies trades at US$354.68, with a 1-day share price return of 4.81% and a 7-day share price return of 6.96%, even though the year-to-date share price return is down 18.38% and the 1-year...
NasdaqCM:UNCY
NasdaqCM:UNCYBiotechs

Unicycive Therapeutics (UNCY) On FDA Setback Still Carries A Fair Value Debate

Unicycive Therapeutics (UNCY) is back in focus after the US Food and Drug Administration issued a Complete Response Letter on its resubmitted New Drug Application for oxylanthanum carbonate, keeping approval on hold over third party manufacturing issues. See our latest analysis for Unicycive Therapeutics. The FDA letter and the recent expansion of Unicycive Therapeutics' at-the-market program have coincided with sharp share price swings, including a 12.58% 1-day share price return, but 7-day...